2025 PACUPrep BCCCP Preparatory Course Dyspnea & Respiratory Symptom Management Recovery, De-escalation, and Transition of Care
Recovery, De-escalation, and Transition of Care

Recovery, De-escalation, and Transition of Care

Learning Objective

Develop a plan to facilitate patient recovery, mitigate long‐term complications, and ensure a safe transition of care.

1. Weaning and De-escalation Protocols

As patients stabilize, objective criteria and stepwise algorithms guide the reduction of ventilatory, hemodynamic, and sedative support to promote recovery and prevent complications associated with prolonged critical care.

A. Criteria for Therapy Reduction and Success

Readiness for weaning is a multi-system assessment. Key criteria include:

  • Hemodynamic stability: Off or on minimal vasopressors (e.g., norepinephrine ≤0.05 mcg/kg/min) with evidence of adequate perfusion, such as lactate clearance and sufficient urine output.
  • Respiratory readiness: Minimal oxygen requirement (FiO₂ ≤40%), low positive end-expiratory pressure (PEEP ≤5 cm H₂O), and a favorable rapid shallow breathing index (RSBI) <105 breaths/min/L.
  • Neurologic alertness: A state of light sedation or calmness, corresponding to a Richmond Agitation-Sedation Scale (RASS) score of –2 to 0.
  • Circulatory support wean: A common strategy involves a coordinated reduction of vasopressors while conservatively removing fluid to avoid circulatory overload.
Key Point

The implementation of nurse-driven daily goals checklists has been shown to shorten the duration of mechanical ventilation and harmonize weaning decisions among the multidisciplinary care team, leading to more consistent and timely liberation from the ventilator.

B. Stepwise Ventilation and Sedation Weaning

A structured, daily approach to weaning sedation and mechanical ventilation is critical. The following flowchart illustrates the typical SAT/SBT process.

Ventilation Weaning Flowchart A flowchart showing the daily process for weaning from mechanical ventilation. It starts with an eligibility screen. If eligible, a Spontaneous Awakening Trial (SAT) is performed. If the SAT is successful, a Spontaneous Breathing Trial (SBT) is performed. Success in the SBT leads to extubation. Failure at any step leads to resuming support and reassessing the next day. 1. Daily Eligibility Screen (Stable, RASS -2 to 0, etc.) 2. Spontaneous Awakening Trial (SAT) (Hold sedation 30-60 min) Failure Resume Light Sedation Reassess Next Day Success 3. Spontaneous Breathing Trial (SBT) (PS ≤8 or T-piece for 30-120 min) Success Extubate Patient Failure Optimize Support Retry Next Day
Figure 1: Stepwise Weaning Protocol. This illustrates the coordinated daily assessment for liberation from sedation (SAT) and mechanical ventilation (SBT), a core component of the ABCDEF bundle.
Clinical Pearl

To minimize the risk of prolonged sedation and facilitate successful Spontaneous Awakening Trials (SATs), consider switching from long-acting benzodiazepines like midazolam to shorter-acting agents such as propofol or dexmedetomidine at least 12–24 hours before a planned weaning attempt.

2. Conversion of Medication Routes

Transitioning intravenous (IV) therapies to enteral routes as gastrointestinal (GI) function recovers is a key de-escalation step. This reduces infection risk from central lines, minimizes fluid overload, lowers costs, and requires careful consideration of bioavailability and formulation factors.

A. IV to Enteral Transition Principles

  • Confirm hemodynamic stability and evidence of intact GI motility (e.g., bowel sounds, passing flatus, tolerating enteral nutrition).
  • Use standard IV-to-oral conversion ratios, recognizing that some drugs require significant dose adjustments (e.g., oral morphine is approximately 2-3 times the IV dose due to first-pass metabolism).
  • Titrate doses gradually over 24–48 hours, closely monitoring for both therapeutic efficacy (e.g., pain or dyspnea control) and adverse effects.
Clinical Pearl

For drugs with high first-pass metabolism, such as opioids (morphine, hydromorphone) and certain β-blockers (propranolol, metoprolol), it is prudent to wait 3–4 half-lives after the first enteral dose before fully assessing its steady-state effect. This prevents premature dose escalation based on an incomplete absorption profile.

B. Enteral Access Tube Considerations

  • Formulation: Never crush sustained-release (SR, ER, XL) or enteric-coated (EC) formulations, as this destroys their delivery mechanism. Consult a pharmacist for liquid or immediate-release alternatives.
  • Flushing: Flush feeding tubes with 20–30 mL of water before and after each medication administration to ensure delivery and maintain tube patency.
  • Interactions: Hold continuous enteral feeds for at least 30 minutes before and after administering drugs known to bind with feeds, such as phenytoin, ciprofloxacin, and levothyroxine.
Tip

Viscous suspensions, like sucralfate or nystatin, should be diluted according to institutional protocol or pharmacist recommendation before administration via a feeding tube to prevent occlusion.

3. Mitigating Post-ICU Syndrome (PICS)

Post-ICU Syndrome (PICS) is a constellation of new or worsened impairments in physical, cognitive, and psychological health that persist after critical illness. Early identification of high-risk patients and prompt application of the ABCDEF bundle are the cornerstones of prevention and mitigation.

A. Risk Stratification and Early Identification

  • Key risk factors: Mechanical ventilation >7 days, deep or prolonged sedation (especially with benzodiazepines), delirium, sepsis, ARDS, and multiple pre-existing comorbidities.
  • Perform daily delirium screenings using a validated tool like the Confusion Assessment Method for the ICU (CAM-ICU).
  • Systematically assess mobility and physical function daily.
  • Document PICS risk factors clearly in handoff communication to ensure continuity of awareness.

B. ABCDEF Bundle Implementation

The ABCDEF bundle is a multicomponent, evidence-based strategy to improve ICU outcomes and reduce the incidence and severity of PICS.

The ABCDEF Bundle for ICU Patient Care
Letter Component Action
A Assess, Prevent, and Manage Pain Use validated scales (e.g., CPOT, BPS) to regularly assess pain and treat with a multimodal approach.
B Both Spontaneous Awakening & Breathing Trials Perform daily, coordinated SATs and SBTs to minimize sedation and hasten ventilator liberation.
C Choice of Analgesia and Sedation Favor non-benzodiazepine sedatives like propofol or dexmedetomidine to reduce delirium and ventilation time.
D Delirium: Assess, Prevent, and Manage Monitor for delirium daily (CAM-ICU) and implement non-pharmacologic prevention strategies (reorientation, sleep hygiene).
E Early Mobility and Exercise Initiate passive range of motion, progressing to active exercise and ambulation as soon as safely possible (often within 48h).
F Family Engagement and Empowerment Involve family in care, provide regular updates, and encourage their presence and participation in decision-making.
Key Fact

Studies have shown that high adherence to the full ABCDEF bundle can reduce the odds of delirium by 50%, decrease the duration of mechanical ventilation by 30%, and lower the risk of in-hospital mortality.

4. Safe Transition and Discharge Planning

A meticulous, pharmacist-led medication reconciliation, structured patient education, and a formal handoff framework are essential to ensure medication safety and continuity of care as patients transition from the ICU to other settings.

A. Comprehensive Medication Reconciliation

  • Build a Best Possible Medication History (BPMH) by interviewing the patient or caregiver and reviewing outpatient pharmacy and medical records.
  • Systematically compare the BPMH with the current ICU medication orders to identify and resolve discrepancies, such as omissions, duplications, or dosing errors.
  • Document the final, reconciled medication list in the electronic health record (EHR) and review it during multidisciplinary rounds.

B. Patient and Caregiver Education

  • Employ the “teach-back” method to confirm understanding of the discharge medication regimen.
  • Provide standardized discharge packets that clearly list medication names, indications, dosing schedules, common side effects, and signs of PICS to watch for.
  • Arrange for post-discharge telehealth or phone follow-up, ideally within 7 days, to assess adherence, answer questions, and address any early complications.

C. Structured Handoff Communication

  • Use a standardized handoff tool like SBAR (Situation, Background, Assessment, Recommendation) when transferring a patient to a step-down unit or communicating with outpatient providers.
  • The handoff should include a concise summary of the ICU course, history of sedation and delirium, documented PICS risk, pending labs, and rehabilitation plans.
  • Ensure all discharge prescriptions are reviewed by a pharmacist to screen for drug-drug interactions and ensure appropriate dosing for the post-ICU setting.
Pearl

Integrating mandatory fields for PICS risk and sedation history into standardized discharge summary templates can effectively alert receiving clinical teams to the patient’s specific post-ICU needs, prompting earlier referrals to physical therapy, occupational therapy, or mental health services.

References

  1. Devlin JW, Skrobik Y, Gelinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
  2. García-Salido A, et al. Post-intensive care syndrome: a narrative review. Front Pediatr. 2025;13:1530984.
  3. Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. J Am Coll Cardiol. 2025;85(10):1234–1247.
  4. DiPiro JT, Talbert RL, Yee GC, et al. Pharmacotherapy: A Pathophysiologic Approach. 11th ed. McGraw-Hill; 2020.
  5. Preiser JC, van Zanten ARH, Berger MM, et al. The authors reply. Crit Care. 2021;25(1):440.
  6. Fremont RD, Kallet RH, Matthay MA. Post-intensive care unit-acquired weakness: a summary of recent clinical research and an agenda for the future. Curr Opin Crit Care. 2014;20(2):177–182.
  7. Royal Children’s Hospital Melbourne. Nursing Guidelines: Enteral Feeding and Medication Administration. 2024.
  8. Parrish CR, McCray S, Copland AP. Navigating the Black Hole of Drug-Nutrient Interactions. Pract Gastroenterol. 2019;May(186):12–35.
  9. Marra A, Ely EW, Pandharipande PP, et al. The ABCDEF Bundle in Critical Care. Crit Care Med. 2017;45(2):321–330.
  10. Hick JL, Hanfling D, Wynia MK, et al. Duty to Plan: Health Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2. ASPR TRACIE. 2023.
  11. Verhaegh EM, Wensing M, van den Bemt PM, et al. The impact of a pharmacist-led medication reconciliation programme on medication-related problems in the intensive care unit: a prospective observational study. J Crit Care. 2018;43:141–147.
  12. World Health Organization. WHO Patient Safety Solutions: Medication Reconciliation. 2014.
  13. Agency for Healthcare Research and Quality. AHRQ Patient Safety Network. SBAR (Situation-Background-Assessment-Recommendation). 2004.
  14. Centers for Medicare & Medicaid Services. CMS Quality Measure Specifications. 2017.
Previous Topic
Back to Lesson
Next Lesson